Rituximab in the treatment of antisynthetase syndrome.
Brulhart
L
L
Waldburger
J-M
JM
Gabay
C
C
D000604:Amino Acyl-tRNA Synthetases / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000276:immunology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D017285:Polymyositis / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D013577:Syndrome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D000069283:Rituximab; D000604:Amino Acyl-tRNA Synthetases